tiprankstipranks
Trending News
More News >
GRAIL Inc (GRAL)
NASDAQ:GRAL
US Market

Compare GRAIL Inc (GRAL) vs. Competitors

Compare
336 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
GRAIL Inc
$96.70
$3.77B
-8.33
455.59%
2 Buy
1 Hold
0 Sell
Moderate Buy
Illumina
$141.65
$21.64B
31.74
3.12%
4 Buy
6 Hold
3 Sell
Hold
Myriad Genetics
$5.92
$551.83M
-1.37
-52.72%
3 Buy
2 Hold
1 Sell
Moderate Buy
NeoGenomics
$12.79
$1.65B
-14.41
-8.51%
5 Buy
6 Hold
0 Sell
Moderate Buy
Natera
$231.25
$31.99B
-101.24
37.24%
15 Buy
2 Hold
0 Sell
Strong Buy
Guardant Health
$112.14
$14.51B
-34.90
200.56%
18 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GRAL
GRAIL Inc
96.70
78.21
422.99%
ILMN
Illumina
141.65
0.34
0.24%
MYGN
Myriad Genetics
5.92
-6.65
-52.90%
NEO
NeoGenomics
12.79
-1.39
-9.80%
NTRA
Natera
231.25
63.79
38.09%
GH
Guardant Health
112.14
67.01
148.48%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts